Abstract: This disclosure relates to systems and methods related to smart sharing options for a shared digital asset (DA) library. An example method performed by a system includes: initiating a camera session; identifying a sharable DA trigger; capturing a DA during the camera session after identifying the sharable DA trigger; and selecting the captured DA for the shared DA library based on the identified sharable DA trigger.

Abstract: Embodiments described herein provide for a non-transitory machine-readable medium storing instructions to cause one or more processors to select a set of content items from a content item collection based upon a temporal relevance and a contextual relevance to a period of time, rank the set of content items based on at least one of a content item category or a content item predefined relevance score, partition the period of time into a set of time slots to schedule for rendering content in an application, rank the set of time slots based on device usage analysis for the period of time, and schedule the set of content items into the set of time slots in accordance with the rankings.

Abstract: The present invention relates to compounds represented by general formula (Ia), (Ib), (IIa) or (IIb). These compounds are suitable for imaging alpha-synuclein and for diagnosing diseases which are associated with the aggregation of alpha-synuclein. The compounds are also useful for treating and preventing diseases which are associated with the aggregation of alpha-synuclein.

Abstract: The present invention relates to a compound represented by the formula (E) which is useful for treating or preventing melanoma.

Abstract: Embodiments described herein provide for a non-transitory machine-readable medium storing instructions to cause one or more processors to select a set of content items from a content item collection based upon a temporal relevance and a contextual relevance to a period of time, rank the set of content items based on at least one of a content item category or a content item predefined relevance score, partition the period of time into a set of time slots to schedule for rendering content in an application, rank the set of time slots based on device usage analysis for the period of time, and schedule the set of content items into the set of time slots in accordance with the rankings.

Abstract: The present invention relates to a compound represented by the formula (E) which is useful for treating or preventing melanoma.

Abstract: The present invention relates to a compound represented by formula (E). The present invention also relates to a compound represented by the formula (E) for use in the treatment or prevention of diseases linked to protein aggregation and/or neurodegenerative diseases. Moreover, the present invention relates to pharmaceutical and diagnostic compositions comprising the compound of the invention as well as to a kit. Furthermore, the present invention relates to a method of imaging deposits of aggregated protein. A kit for preparing a detectably labelled compound of the present invention is also disclosed.

Abstract: The present invention is concerned with derivatives of 3,5-diphenyl-diazole compounds, which are effective therapeutic agents for use in treating diseases linked to protein aggregation and/or neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), and Transmissible spongiform encephalopathies (TSEs) such as Creutzfeldt-Jakob disease (CJD). The therapeutic effect is caused by the inhibition of the protein aggregation in the affected tissue, such as the brain. 3,5-Diphenyl-diazole derivatives have been shown to be effective in inhibiting aggregation of proteins but are also characterized by their poor solubility in aqueous solutions. The prodrugs of the invention are modified 3,5-diphenyl-diazole derivatives, which are characterized by their improved solubility in aqueous solutions, and by their increased bioavailability.

Abstract: The present invention is concerned with derivatives of 3,5-diphenyl-diazole compounds, which are effective therapeutic agents for use in treating diseases linked to protein aggregation and/or neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), and Transmissible spongiform encephalopathies (TSEs) such as Creutzfeldt-Jakob disease (CJD). The therapeutic effect is caused by the inhibition of the protein aggregation in the affected tissue, such as the brain. 3,5-Diphenyl-diazole derivatives have been shown to be effective in inhibiting aggregation of proteins but are also characterized by their poor solubility in aqueous solutions. The prodrugs of the invention are modified 3,5-diphenyl-diazole derivatives, which are characterized by their improved solubility in aqueous solutions, and by their increased bioavailability.

Abstract: The present invention relates to a compound represented by formula (E). The present invention also relates to a compound represented by the formula (E) for use in the treatment or prevention of diseases linked to protein aggregation and/or neurodegenerative diseases. Moreover, the present invention relates to pharmaceutical and diagnostic compositions comprising the compound of the invention as well as to a kit. Furthermore, the present invention relates to a method of imaging deposits of aggregated protein. A kit for preparing a detectably labelled compound of the present invention is also disclosed.

Abstract: A communication device is configured to store one or more aggregator service application modules for use in accessing one or more different aggregator, services. Each aggregator service offers access through a plurality of offered wireless networks identified by a plurality of offered wireless network identifiers. The communication device maintains a prioritized list of profiles which include one or more aggregator service profiles associated with the one or more aggregator services. A scanning operation is performed for identifying one or more available wireless networks in a geographic area of the device, for producing a scan list of one or more available wireless network identifiers corresponding to the one or more available wireless networks. One of the aggregator service profiles is selected from the prioritized list, causing one of the aggregator service application modules corresponding to the selected profile to be invoked.

Abstract: The present invention relates to a compound represented by formula (E). The present invention also relates to a compound represented by the formula (E) for use in the treatment or prevention of diseases linked to protein aggregation and/or neurodegenerative diseases. Moreover, the present invention relates to pharmaceutical and diagnostic compositions comprising the compound of the invention as well as to a kit. Furthermore, the present invention relates to a method of imaging deposits of aggregated protein. A kit for preparing a detectably labelled compound of the present invention is also disclosed.

Abstract: The present invention relates to a compound represented by formula (E). The present invention also relates to a compound represented by the formula (E) for use in the treatment or prevention of diseases linked to protein aggregation and/or neurodegenerative diseases. Moreover, the present invention relates to pharmaceutical and diagnostic compositions comprising the compound of the invention as well as to a kit. Furthermore, the present invention relates to a method of imaging deposits of aggregated protein. A kit for preparing a detectably labelled compound of the present invention is also disclosed.

Abstract: A communication device is configured to store one or more aggregator service application modules for use in accessing one or more different aggregator, services. Each aggregator service offers access through a plurality of offered wireless networks identified by a plurality of offered wireless network identifiers. The communication device maintains a prioritized list of profiles which include one or more aggregator service profiles associated with the one or more aggregator services. A scanning operation is performed for identifying one or more available wireless networks in a geographic area of the device, for producing a scan list of one or more available wireless network identifiers corresponding to the one or more available wireless networks. One of the aggregator service profiles is selected from the prioritized list, causing one of the aggregator service application modules corresponding to the selected profile to be invoked.

Abstract: A communication device is configured to store one or more aggregator service application modules for use in accessing one or more different aggregator services. Each aggregator service offers access through a plurality of offered wireless networks identified by a plurality of offered wireless network identifiers. The communication device maintains a prioritized list of profiles which include one or more aggregator service profiles associated with the one or more aggregator services. A scanning operation is performed for identifying one or more available wireless networks in a geographic area of the device, for producing a scan list of one or more available wireless network identifiers corresponding to the one or more available wireless networks. One of the aggregator service profiles is selected from the prioritized list, causing one of the aggregator service application modules corresponding to the selected profile to be invoked.

Abstract: To reduce automatically a number of enabled connection profiles in a mobile station, for example, while the number of enabled connection profiles is at its maximum, a mobile station automatically selects one of the existing enabled connection profiles to disable and automatically disables the auto-selected connection profile.

Abstract: To reduce automatically a number of enabled connection profiles in a mobile station, for example, while the number of enabled connection profiles is at its maximum, a mobile station automatically selects one of the existing enabled connection profiles to disable and automatically disables the auto-selected connection profile.

Abstract: A communication device is configured to store one or more aggregator service application modules for use in accessing one or more different aggregator services. Each aggregator service offers access through a plurality of offered wireless networks identified by a plurality of offered wireless network identifiers. The communication device maintains a prioritized list of profiles which include one or more aggregator service profiles associated with the one or more aggregator services. A scanning operation is performed for identifying one or more available wireless networks in a geographic area of the device, for producing a scan list of one or more available wireless network identifiers corresponding to the one or more available wireless networks. One of the aggregator service profiles is selected from the prioritized list, causing one of the aggregator service application modules corresponding to the selected profile to be invoked.

Abstract: The present invention relates to a compound represented by formula (E). The present invention also relates to a compound represented by the formula (E) for use in the treatment or prevention of diseases linked to protein aggregation and/or neurodegenerative diseases. Moreover, the present invention relates to pharmaceutical and diagnostic compositions comprising the compound of the invention as well as to a kit. Furthermore, the present invention relates to a method of imaging deposits of aggregated protein. A kit for preparing a detectably labelled compound of the present invention is also disclosed. Formula (E) wherein X, Y and L are independently nondirectionally selected from —C(R1)(R2)—, —C(R3)?, —N(R4)—, —N?, —N+(R5)?, —O— and —S—; M and Z are independently nondirectionally selected from formula (I) and formula (II).

Abstract: The invention relates to a method of preparing lithium complex salts and their intermediaries and to the use of these in electrolytes.